Conference Program

Download Conference Program PDF
View Satellite Symposia Schedule

Wednesday, 13 January, 2021
All Day Exhibit Setup
10:00 – 19:00 Registration Open
10:00 – 19:00 Poster Setup
12:00 – 16:00 TOXINS 101 Preconference Workshop
Learn more
18:00 – 19:30 Opening Session
Chair: Cynthia Comella (USA)
18:00 – 18:30 Welcome and Opening Remarks and Lifetime Achievement Awards Ceremony
Co-chairs:
TBD (Country)
18:30 – 19:00 Presentation by Basic Science Lifetime Achievement Award Recipient
TBD (Country)
19:00 – 19:30 Presentation by Clinical Lifetime Achievement Award Recipient
TBD (Country)
19:30 – 22:00 Welcome Reception – Exhibits and Posters

 

Thursday, 14 January, 2021
07:00 – 18:30 Registration/Information
07:00 – 08:30 Breakfast
08:30 – 12:00 Plenary Session
Pain and Sensory Mechanisms
Chair: Mark Hallett (USA)
08:30 – 08:40 Opening Remarks and Introduction of Keynote Speaker
08:40 – 09:30 Keynote Presentation – The Neuromuscular Junction
Silvio Rizzoli (Germany)
09:30 – 10:00 Clinical Implications of Muscle Physiology
Preeti Raghavan (USA)
10:00 – 10:30 Basis of Movement Control and Why Botulinum Toxin Should Influence It
John Rothwell (UK)
10:30 – 11:00 Exhibits & BREAK
11:00 – 12:00 Guidance, Localization, Optimal Placement of Botulinum Toxin: What Works Best?
Hannes Gruber (USA)
Katharine Alter (USA)
Joseph Jankovic (USA)
12:00 – 13:30 Lunch
12:00 – 13:30 Lunch Satellite Symposium
12:00 – 14:30 Exhibits
12:00 – 14:30 Poster Session

 

PARALLEL TRACKS Basic Science Track   Clinical Track 1A   Clinical Track 2A   Clinical Workshop 1A   Clinical Workshop 2A   Clinical Workshop 3A   Clinical Workshop 4A   Clinical Workshop 5A
14:30 – 16:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 16:00 Genitourinary and Gastrointestinal Botulinum Toxin Applications
Session Chair: Michael Chancellor (USA)		 14:30 – 16:00 Ultrasound Didactic
Session Chair: Michael Chancellor (USA)		 14:30 – 16:00 Miscellaneous
Session Chair: Steven G. Yoelin (USA)		 14:30 – 16:00 Spasticity
Session Chair: Cynthia Comella (USA)		 14:30 – 16:00 Emerging uses
Session Chair: Alberto Esquenazi (USA)		 14:30 – 16:00 Cadaver Laboratory
Session Chair: Andrew Blitzer (USA)		 14:30 – 16:00 Hands-on Ultrasound Guidance Workshop
Session Chair: Katharine Alter (USA)
Learn more
14:30 – 15:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 15:00 Update on Bladder Botulinum Toxin Applications
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 15:00 Ultrasonography
Co-chairs:
Name (USA)
Name (Finland)

  1. Evidence-based use of ultrasonography
  2. Ultrasound elastography
  3. Ultrasound identification of innervation bands
 14:30 – 15:00 Temporomandibular junction
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 15:00 Update on published data on early spasticity management with BoNT
-Do we have evidence to start with BoNT injections in patients at risk for disabling spasticity?
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 15:00 Neurodegenerative diseases
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 16:00 Face and Neck
Prosectors::
Name (USA)
Name (Finland)

Discussants::
Name (USA)
Name (Finland)		 14:30 – 16:00 Head & Neck
Prosectors::
Name (USA)
Name (Finland)

Discussants::
Name (USA)
Name (Finland)
15:00 – 15:30 Title
Co-chairs:
Name (USA)
Name (Finland)		 15:00 – 15:30 Urology: Social and economical impact of Bladder injections in SCI and MS
Co-chairs:
Name (USA)
Name (Finland)		 15:00 – 15:30 Ultrasound injection guidance: Put the right dose to the right place
Co-chairs:
Name (USA)
Name (Finland)

  • Does ultrasound add to indication and prediction of BoNT management in spastic movement disorder (SMD) and dystonia
  • Ultrasound monitoring of muscle/tissue volume: Nice to have or implications?
 15:00 – 15:30 Early vs Late BoNT management of SMD
– Definition of “early” and “late” start and the rationale for early start of BoNT management in SMD
Co-chairs:
Name (USA)
Name (Finland)		 15:00 – 15:30 Adjunctive therapies in adult and pediatric spasticity management
Co-chairs:
Name (USA)
Name (Finland)		 15:00 – 15:30 Parkinsonism
Co-chairs:
Name (USA)
Name (Finland)
15:30 – 16:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 15:30 – 16:00 Pelvic Floor Application of Botulinum Toxin
Co-chairs:
Name (USA)
Name (Finland)		 15:30 – 16:00 Ultrasound assessment of deep muscles in the lower limb
Co-chairs:
Name (USA)
Name (Finland)		 15:30 – 16:00 2 Podium Abstracts
– 10 minutes with 5-min Q&A for each abstract – 30 minutes
Co-chairs:
Name (USA)
Name (Finland)		 15:30 – 16:00 2 Podium Abstracts
– 10 minutes with 5-min Q&A for each abstract – 30 minutes
Co-chairs:
Name (USA)
Name (Finland)		 15:30 – 16:00 Novel therapeutic indications and cancer
Co-chairs:
Name (USA)
Name (Finland)
16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK
PARALLEL TRACKS Basic Science Track   Clinical Track 1B   Clinical Track 2B   Clinical Workshop 1B   Clinical Workshop 2B   Clinical Workshop 3B   Clinical Workshop 4B   Clinical Workshop 5B
16:30 – 18:30 Title
Co-chairs:
Mauricio Montal (USA)
Thomas Binz (Germany)		 16:30 – 18:30 From Bench to Bedside
Session Chair: Francisco Cardoso (Brazil)		 16:30 – 18:30 Cervical dystonia
Session Chair: Francisco Cardoso (Brazil)		 16:30 – 18:30 Aesthetic uses
Moderator: Steven G. Yoelin (USA)		 16:30 – 18:30 Adult spasticity
Moderator: Carlos Singer (USA)		 16:30 – 18:30 Blepharospam and Hemifacial Spasm
Moderator: Anthony Ward (UK)		 16:30 – 18:30 Cadaver Laboratory
Moderator: Stewart Factor (USA)		 16:30 – 18:30 Hands-on Ultrasound Guidance Workshop
Session Chair: Katharine Alter (USA)
Learn more
16:30 – 17:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 Clinical profile of BoNT response/ Immunogenicity
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 Mythic deep muscles
“when to think about them, where to find them”: Video case studies
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 Upper face
Lower face
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 BoNT in spinal cord injury (SCI) management
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 How to adjust expectations of a newly diagnosed BSP patient
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 Demonstrations on Live Patients
Master Injector:
Gohar Nikoghosyan-Bossen (Denmark)
Master Injector: Heidi Bryde Biernat (Denmark)		 16:30 – 18:00

Upper Limb
Co-chairs:
Name (USA)
Name (Finland) 

 

 

 
17:00 – 17:30 Title
Co-chairs:
Name (USA)
Name (Finland)		 17:00 – 17:45

Emerging Toxins in Neurorehabilitation
Co-chairs:
Name (USA)
Name (Finland)

  1. Type E Neurotoxin
  2. DaxibotulinumtoxinA
  3. Clinical differences between A1 and A2 botulinum toxin subtypes

45 Minutes

 17:00 – 17:30 The yo-yo effect in dystonia
Co-chairs:
Name (USA)
Name (Finland)		 17:00 – 17:30 Correcting facial asymmetries
Co-chairs:
Name (USA)
Name (Finland)		 17:00 – 18:30 Injection demonstrations and/or video case studies
Co-chairs:
Name (USA)
Name (Finland)		 17:00 – 17:30 Non responder BSP patients to BoNT; who are they?
Co-chairs:
Name (USA)
Name (Finland)		 17:00 – 17:30 Title
Co-chairs:
Name (USA)
Name (Finland)		  
17:30 – 18:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 17:45 – 18:30 Clinical aspects associated with BoNT properties
– Does altering the onset of action and increasing duration of action really matter in clinical practice?
Co-chairs:
Name (USA)
Name (Finland)

45 Minutes

 17:30 – 18:00 Long term satisfaction with BoNT
Co-chairs:
Name (USA)
Name (Finland)		 17:30 – 18:00 Micro Tox for improving skin quality OR Combining toxins and fillers for optimal results
Co-chairs:
Name (USA)
Name (Finland)		 17:30 – 18:00 Surgery for non responders BSP
Co-chairs:
Name (USA)
Name (Finland)		 17:30 – 18:00 Title
Co-chairs:
Name (USA)
Name (Finland)		  
18:00 – 18:30 Title
Co-chairs:
Name (USA)
Name (Finland)		 18:00 – 18:30 Functional dystonia: Should we inject BoNT?
Co-chairs:
Name (USA)
Name (Finland)		 18:00 – 18:30 The younger patient (Millennials and Generation X)
Co-chairs:
Name (USA)
Name (Finland)		 18:00 – 18:30 Injection demonstrations and/or video case studies Complex HFS and Bleph
Co-chairs:
Name (USA)
Name (Finland)		 18:00 – 18:30 Title
Co-chairs:
Name (USA)
Name (Finland)		    

 

Friday, 15 January, 2021
07:00 – 18:30 Registration/ Information
07:00 – 08:30 Breakfast
08:30 – 12:00 Plenary Session
TITLE TO ADD
Co-chairs:
TBD (Country)
TBD (Country)
08:30 – 09:00 The Anatomy of Skin and It’s Neurological Control
Fiona Watt (UK)
09:00 – 09:30 Botulinum Toxin and Surgical Intervention and the Effect on Wound Healing
François Genet (France)
09:30 – 10:00 Targeting Botulinum Toxin to Distal Sites and Diverse Nerve Terminals
Mateo Caleo (Italy)
10:00 – 10:30 Break
10:30 – 11:00 The Role of Botulinum Toxin in Treatment of Depression
M. Axel Wollmer (Germany)
11:00 – 11:30 Antipruitic Effect of Botulinum Toxins
Parisa Gazerani (Denmark)
11:30 – 12:00 The Emerging Role of Botulinum Toxin in Cardiology
TBD (Country)
12:00 – 13:30 Lunch
12:00 – 14:30 Exhibits
12:00 – 14:30 Poster Session

 

PARALLEL TRACKS Basic Science Track   Clinical Track 1A   Clinical Track 2A   Clinical Workshop 1A   Clinical Workshop 2A   Clinical Workshop 3A   Clinical Workshop 4A   Clinical Workshop 5A
14:30 – 16:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 16:00 Limb & Tremor
Session Chair: Michael Chancellor (USA)		 14:30 – 16:00 Craniocervical dystonia (Meige syndrome)
Session Chair: Michael Chancellor (USA)		 14:30 – 16:00 Aesthetic and Dermatologic uses
Session Chair: Steven G. Yoelin (USA)		 14:30 – 16:00 Cerebral palsy (CP)
Session Chair: Cynthia Comella (USA)		 14:30 – 16:00 Lower Cranial Dystonias and Drooling
Session Chair: Alberto Esquenazi (USA)		 14:30 – 16:00 Cadaver Laboratory
Session Chair: Andrew Blitzer (USA)		 14:30 – 16:00 Hands-on Ultrasound Guidance Workshop
Session Chair: Katharine Alter (USA)
Learn more
14:30 – 15:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 15:00 How to evaluate a patient and choose the appropriate muscles
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 15:00 Clinical phenotypes of cranio-cervical dystonia
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 15:00 Update on hyperhidrosis – (axillary, palmar, and craniofacial)
50 minutes
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 15:00 Results in upper and lower limb management: Are there any differences related to the toxin or injection technique used?
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 15:00 Update on latest clinical data
Co-chairs:
Name (USA)
Name (Finland)		 14:30 – 16:00 Neck and Upper Torso
Prosectors::
Name (USA)
Name (Finland)

Discussants::
Name (USA)
Name (Finland)		 14:30 – 16:00 Title
Co-chairs:
Name (USA)
Name (Finland)

Title
Co-chairs:
Name (USA)
Name (Finland)
15:00 – 15:30 Title
Co-chairs:
Name (USA)
Name (Finland)		 15:00 – 15:30 Update on latest clinical data
Co-chairs:
Name (USA)
Name (Finland)		 15:00 – 15:30 BoNT in Meige syndrome
Co-chairs:
Name (USA)
Name (Finland)		 15:00 – 15:30 New toxins in aesthetic and dermatologic uses Podium Presentation #1
20 minutes
Co-chairs:
Name (USA)
Name (Finland)		 15:00 – 15:30 Side effects in upper and lower limb management: Are there any differentces related to the product or Gross Motor Function Classification System (GMFCS) stage?
Co-chairs:
Name (USA)
Name (Finland)		 15:00 – 16:00 Video case studies
Co-chairs:
Name (USA)
Name (Finland)
15:30 – 16:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 15:30 – 16:00 2 Podium Abstracts
10 minutes with 5-min Q&A for each abstract – 30 mintues
Co-chairs:
Name (USA)
Name (Finland)		 15:30 – 16:00 Lingual dystonia
Co-chairs:
Name (USA)
Name (Finland)		 15:30 – 16:00 New toxins in aesthetic and dermatologic uses Podium Presentation #2
20 minutes
Co-chairs:
Name (USA)
Name (Finland)		 15:30 – 16:00 Specific adjunctive therapy in CP Management with BoNT and how much is necessary?
Co-chairs:
Name (USA)
Name (Finland)		  
16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK 16:00 – 16:30 BREAK TIME BREAK
PARALLEL TRACKS Basic Science Track   Clinical Track 1B   Clinical Track 2B   Clinical Workshop 1B   Clinical Workshop 2B   Clinical Workshop 3B   Clinical Workshop 4B   Clinical Workshop 5B
16:30 – 18:30 Mode of Action of BoNTs
Co-chairs:
Mauricio Montal (USA)
Thomas Binz (Germany)		 16:30 – 18:30 Genitourinary and Gastrointestinal Botulinum Toxin Applications
Session Chair: Francisco Cardoso (Brazil)		 16:30 – 18:30 Cervical dystonia
Session Chair: Francisco Cardoso (Brazil)		 16:30 – 18:30 Aesthetic and dermatologic uses – Injection Workshop – Live Demonstrations
Moderator: Steven G. Yoelin (USA)		 16:30 – 18:30 Cerebral palsy
Moderator: Carlos Singer (USA)		 16:30 – 18:30 Headache and pain
Moderator: Anthony Ward (UK)		 16:30 – 18:30 Cadaver Laboratory
Moderator: Stewart Factor (USA)		 16:30 – 18:30 Hands-on Ultrasound Guidance Workshop
Session Chair: Katharine Alter (USA)
Learn more
16:30 – 17:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 Prostate Botulinum Toxin Injection and Treatment of Toxin Related Side Effects
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 2 Podium Abstracts
– 10 minutes with 5-min Q&A for each abstract – 30 minutes
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 18:30 Title
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 Podium Presentation
20 minutes
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 17:00 Mechanisms of action of botulinum toxin in pain and migraine
Co-chairs:
Name (USA)
Name (Finland)		 16:30 – 18:00 Lower Limb
Prosectors::
Name (USA)
Name (Finland)

Discussants::

Name (USA)

Name (Finland)		 16:30 – 18:00 Title
Co-chairs:
Name (USA)
Name (Finland)
17:00 – 17:30 Title
Co-chairs:
Name (USA)
Name (Finland)		 17:00 – 18:00 GI-indictions – Development of gastro-intestinal indications of BoNT and potential limitations of it use
Co-chairs:
Name (USA)
Name (Finland)		 17:00 – 18:30 Live injections or video cases
Co-chairs:
Name (USA)
Name (Finland)		   17:00 – 17:30 Podium Presentation
20 minutes
Co-chairs:
Name (USA)
Name (Finland)		 17:00 – 17:30 Botulinum toxin for chronic migraine: time for a change?
Sutures or muscles: the science beyond the choice
Co-chairs:
Name (USA)
Name (Finland)		    
17:30 – 18:00 Title
Co-chairs:
Name (USA)
Name (Finland)		 17:30 – 18:00 2 Podium Abstracts
– 10 minutes with 5-min Q&A for each abstract – 30 minutes

Co-chairs:

Name (USA)

Name (Finland)		     17:30 – 18:00 Video case studies
Co-chairs:
Name (USA)
Name (Finland)		 17:30 – 18:00 A new paradigm based on echo-guided injection into the sutures
Co-chairs:
Name (USA)
Name (Finland)		    
18:00 – 18:30 Title
Co-chairs:
Name (USA)
Name (Finland)		           18:00 – 18:30 Trigeminal neuralgia
Co-chairs:
Name (USA)
Name (Finland)		        

 

Saturday, 16 January, 2021
07:00 – 12:00 Registration/ Information
07:00 – 08:30  Breakfast
08:00 – 09:00 INA Members Business Meeting
09:00 – 11:30 Plenary Session –
Chair: TBD (Country)
09:00 – 09:30 Placebo Effect of Botulinum Toxin

Marina A J Tijssen (Netherlands)
09:30 – 10:00 Membrane Insertion of Botulinum Toxin

Rongshen Jin (USA)
10:00 – 10:30 Botulinum Toxin In Pain Management: Beyond Migraine: Trigeminal Neuralgia
TBD (?)
10:30 – 10:50 Best Basic Science Abstract
TBD (?)
10:50 – 11:10 Best Clinical Abstract
TBD (USA)
11:10 – 11:30 Closing Remarks & Poster Awards
Cynthia Comella (USA)